Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma

BMC Cancer201717:618

https://doi.org/10.1186/s12885-017-3634-5

Received: 22 May 2017

Accepted: 28 August 2017

Published: 5 September 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
22 May 2017 Submitted Original manuscript
25 May 2017 Reviewed Reviewer Report - Clancy Clark
13 Jun 2017 Reviewed Reviewer Report - Amarpreet Bhalla
10 Jul 2017 Author responded Author comments - Basile Tessier-Cloutier
Resubmission - Version 2
10 Jul 2017 Submitted Manuscript version 2
22 Jul 2017 Reviewed Reviewer Report - Amarpreet Bhalla
6 Aug 2017 Author responded Author comments - Basile Tessier-Cloutier
Resubmission - Version 3
6 Aug 2017 Submitted Manuscript version 3
23 Aug 2017 Author responded Author comments - Basile Tessier-Cloutier
Resubmission - Version 4
23 Aug 2017 Submitted Manuscript version 4
Publishing
28 Aug 2017 Editorially accepted
5 Sep 2017 Article published 10.1186/s12885-017-3634-5

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Division of Anatomical Pathology, Vancouver General Hospital
(2)
Department of Pathology & Laboratory Medicine, University of British Columbia
(3)
Division of Medical Oncology, University of British Columbia
(4)
Genetic Pathology Evaluation Centre, University of British Columbia
(5)
Pancreas Centre BC
(6)
Deeley Research Centre, British Columbia Cancer Agency
(7)
Division of Medical Oncology, British Columbia Cancer Agency
(8)
Department of Biochemistry and Microbiology, University of Victoria
(9)
Department of Anatomical Pathology, Abbotosford Regional Hospital and Cancer Centre

Advertisement